Anzeige
Mehr »
Mittwoch, 02.07.2025 - Börsentäglich über 12.000 News
Nach dem Genius Act: Dieses börsennotierte XRP-Unternehmen greift im Token-Finanzmarkt an!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Contract Pharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
Dibluebird bio Bolsters Management Team with Appointments
DiFrontage Expands Business in Canada with New Leadership
DiBioMarin Completes Acquisition of Inozyme Pharma for $270M
DiMerck KGaA, Darmstadt, Germany Acquires SpringWorks Therapeutics for $3.4M
DiFresenius Expands Biosimilars Portfolio with Denosumab Biosimilars in the U.S.
MoAAPS Reveals Opening & Closing Plenary Speakers for 2025 PharmSci 360
MoParticle Dynamics Acquires EUROAPI UK
MoUI Pharmaceuticals Partners with MimiVax for Glioblastoma Vaccine
MoKeystone Folding Box Co., Med-Con Technologies Partner to Enhance Key-Pak
MoPiramal Pharma Solutions Breaks Ground on New Expansion
MoVeranova Appoints Dr. Matteo Villain as VP of Peptides & Oligonucleotides
MoProFound Therapeutics Inks $70M+ Deal with Novartis
MoFDA Approves Takeda's Gammagard Liquid ERC
MoMabion, NovalGen Partner to Bring NVG-222 to Market
MoCircio, NeoRegen Biotech to Advance Circular RNA Delivery Collaboration
MoHikma Pharmaceuticals to Invest $1B in U.S. Manufacturing & R&D Capabilities
FrVetter Breaks Ground on Des Plaines Manufacturing Site
FrFDA Approves REMS Programs in BMS Cell Therapy Labels
FrPrioBio Opens Flagship Cell & Gene Therapy Center of Excellence in Hopewell, NJ
DoGenSight Transfers Upstream Phase of LUMEVOQ Manufacturing Process to Catalent
DoIncyte Appoints Bill Meury Chief Executive Officer
DoAGC Biologics Expands Cell Therapy Development Operations to Asia
25.06.MAIA Biotechnology, Roche Partner for Hard-to-Treat Cancer Therapies
25.06.Silo Pharma, Hoth Therapeutics Enter LOI to Develop Obesity Treatment
25.06.Bio-Thera & SteinCares Ink Dupilumab Biosimilar Deal for Latin America